Quiver Bioscience Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3M

  • Investors
  • 4

Quiver Bioscience General Information

Description

Developer of a neuroscience research platform designed to accelerate the discovery of therapeutics for central nervous system disorders. The company offers advanced human cellular models, measurement engineering, and artificial intelligence-driven analysis for neuronal activity and drug response, enabling life sciences researchers and pharmaceutical organizations to identify and develop therapeutics for chronic pain and neurodevelopmental disorders.

Contact Information

Formerly Known As
Q-State Biosciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 150 Cambridge Park Drive
  • 5th Floor
  • Cambridge, MA 02140
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Enterprise Systems (Healthcare)
Corporate Office
  • 150 Cambridge Park Drive
  • 5th Floor
  • Cambridge, MA 02140
  • United States
+1 (617)

Quiver Bioscience Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quiver Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
20. Later Stage VC 21-Oct-2026 $3M Completed Pre-Clinical Trials
19. Grant 01-Jul-2025 Completed Pre-Clinical Trials
18. Later Stage VC 01-Jan-2025 Completed Pre-Clinical Trials
17. Buyout/LBO 05-Jul-2023 Completed Pre-Clinical Trials
16. Grant 01-Jan-2022 Completed Pre-Clinical Trials
15. Grant 20-Jul-2021 Completed Pre-Clinical Trials
14. Later Stage VC (Series A1) 31-Mar-2021 Completed Pre-Clinical Trials
13. Grant 30-Sep-2020 Completed Startup
12. Debt - PPP 09-Apr-2020 $1.29M $31.2M Completed Startup
11. Later Stage VC (Series B) 14-Feb-2020 $21.2M $31.2M Completed Startup
To view Quiver Bioscience’s complete valuation and funding history, request access »

Quiver Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a neuroscience research platform designed to accelerate the discovery of therapeutics for central nervous s
Drug Discovery
Cambridge, MA
26 As of 2026

South San Francisco, CA
 

Bedford, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Quiver Bioscience Competitors (3)

One of Quiver Bioscience’s 3 competitors is insitro, a Venture Capital-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
insitro Venture Capital-Backed South San Francisco, CA
Stoke Therapeutics Formerly VC-backed Bedford, MA
Wave Therapeutics Venture Capital-Backed Nashville, IN
You’re viewing 3 of 3 competitors. Get the full list »

Quiver Bioscience Patents

Quiver Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2025507683-A Therapeutic agents for syngap haploinsufficiency Pending 24-Feb-2022
WO-2023163801-A1 Therapeutics for syngap haploinsufficiency Inactive 24-Feb-2022
CA-3233095-A1 Therapeutics for haploinsufficiency conditions Pending 23-Sep-2021
WO-2023049800-A1 Therapeutics for haploinsufficiency conditions Inactive 23-Sep-2021
JP-2024534574-A Treatment for haploinsufficient conditions Pending 23-Sep-2021 C12N15/113
To view Quiver Bioscience’s complete patent history, request access »

Quiver Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quiver Bioscience Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Porta (Beverages) Corporation
Pimlico Pond Investments Family Office Minority
Exponential Capital (Atlanta) Venture Capital Majority
National Institutes of Neurological Disorders and Stroke Government
To view Quiver Bioscience’s complete investors history, request access »

Quiver Bioscience Acquisitions (1)

Quiver Bioscience’s most recent deal was a Merger/Acquisition with Claritas Genomics. The deal was made on 09-Feb-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Claritas Genomics 09-Feb-2018 Merger/Acquisition Laboratory Services (Healthcare)
To view Quiver Bioscience’s complete acquisitions history, request access »

Quiver Bioscience FAQs

  • When was Quiver Bioscience founded?

    Quiver Bioscience was founded in 2013.

  • Where is Quiver Bioscience headquartered?

    Quiver Bioscience is headquartered in Cambridge, MA.

  • What is the size of Quiver Bioscience?

    Quiver Bioscience has 26 total employees.

  • What industry is Quiver Bioscience in?

    Quiver Bioscience’s primary industry is Drug Discovery.

  • Is Quiver Bioscience a private or public company?

    Quiver Bioscience is a Private company.

  • What is Quiver Bioscience’s current revenue?

    The current revenue for Quiver Bioscience is .

  • How much funding has Quiver Bioscience raised over time?

    Quiver Bioscience has raised $3M.

  • Who are Quiver Bioscience’s investors?

    Porta (Beverages), Pimlico Pond Investments, Exponential Capital (Atlanta), and National Institutes of Neurological Disorders and Stroke have invested in Quiver Bioscience.

  • Who are Quiver Bioscience’s competitors?

    insitro, Stoke Therapeutics, and Wave Therapeutics are competitors of Quiver Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process